The rising interest in GLP-1 agonists for metabolic conditions has generated a discussion about formats: skin-applied devices versus capsules. Traditionally , GLP-1 treatments were exclusively available in tablet form, but the emergence of skin applications provides a alternative way. Transdermal systems might suit individuals with difficulty wi… Read More